Virbac, a veterinary pharmaceutical company, has launched Trilotab, a new medication for treating Cushing's disease in dogs. Unlike Vetoryl, each Trilotab tablet can be divided, which makes it easier to tailor to a dog's needed dose. It's also flavored and chewable.
Please note, Trilotab is currently only available in the UK and European Union. For more information, please see the following: